Periodontal bacteria produce proteases that inactivate antimicrobial peptides, potentially explaining how these pathogens evade the mouth's natural immune defenses and establish chronic infections.
Protease evasionPeriodontal bacteria actively destroy antimicrobial peptides with secreted proteases, not just resisting them passively
What the researchers found
Periodontal pathogens P. gingivalis and Prevotella spp. produce extracellular proteases that degrade and inactivate antimicrobial peptides, representing a bacterial evasion mechanism against innate immune defenses in the oral cavity.
Why it matters
If oral bacteria can destroy the mouth's antimicrobial peptide defenses, this provides a mechanism for chronic gum disease and suggests that protease-resistant peptide antibiotics might be needed to treat periodontal infections.
How the study worked
In-vitro study using double-layer agarose diffusion assays and broth microdilution assays to test antimicrobial peptide activity against periodontal bacteria, with culture supernatant experiments to assess protease-mediated inactivation.
What this study cannot tell us
In-vitro study; protease activity in the complex oral environment may differ. Not all periodontal bacteria were tested. The relative importance of this evasion mechanism versus other virulence factors is unclear.
How to read the evidence
Preliminary in-vitro evidence demonstrating a clear mechanism of antimicrobial peptide evasion by clinically relevant oral pathogens.
When this study was published
Published in 1999. Bacterial protease-mediated antimicrobial peptide resistance has since been recognized as an important virulence mechanism across many pathogen species.
The bigger picture
Antimicrobial resistance isn't limited to traditional antibiotics. Bacteria can also evolve resistance to the body's natural antimicrobial peptides, which has implications for developing peptide-based therapeutics that need to resist bacterial proteases.
Questions still open
- Can protease-resistant antimicrobial peptides be designed for periodontal treatment?
- Do other pathogenic bacteria use similar protease-based evasion strategies?
- Could protease inhibitors enhance natural antimicrobial peptide defenses in the mouth?
Common questions
Why does gum disease persist despite the mouth's defenses?
Could this lead to better dental treatments?
Read the original research
Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp.
Microbiology (Reading, England), 145 ( Pt 4), 965-971
Citation
Devine, D A; Marsh, P D; Percival, R S; Rangarajan, M; Curtis, M A. (1999). Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp.. Microbiology (Reading, England), 145 ( Pt 4), 965-971. https://doi.org/10.1099/13500872-145-4-965